blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP1563308

EP1563308 - METHODS AND KITS FOR DIAGNOSING TUMORIGENICITY [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  24.08.2012
Database last updated on 15.06.2024
Most recent event   Tooltip04.10.2013Lapse of the patent in a contracting state
New state(s): HU		published on 06.11.2013  [2013/45]
Applicant(s)For all designated states
A & G Pharmaceutical, Inc.
9130 Red Branch Road Suite U/V
Columbia, MD 21045 / US
[2006/21]
Former [2005/33]For all designated states
A & G Pharmaceuticals, Inc.
9130 Red Branch Road, Suite U/V
Baltimore, MD 21045 / US
Inventor(s)01 / SERRERO, Ginette
10200 Savoy Ct.
Ellicott City, MD 21042 / US
 [2005/33]
Representative(s)Pilkington, Stephanie Joan
Potter Clarkson LLP The Belgrave Centre
Talbot Street
Nottingham NG1 5GG / GB
[N/P]
Former [2011/42]Pilkington, Stephanie Joan
Potter Clarkson LLP Park View House 58 The Ropewalk Nottingham
NG1 5DD / GB
Former [2005/33]Pilkington, Stephanie Joan
Eric Potter Clarkson Park View House 58 The Ropewalk
Nottingham NG1 5DD / GB
Application number, filing date03776580.727.10.2003
[2005/33]
WO2003US34146
Priority number, dateUS2002028116028.10.2002         Original published format: US 281160
[2005/33]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO2004039244
Date:13.05.2004
Language:EN
[2004/20]
Type: A2 Application without search report 
No.:EP1563308
Date:17.08.2005
Language:EN
The application published by WIPO in one of the EPO official languages on 13.05.2004 takes the place of the publication of the European patent application.
[2005/33]
Type: B1 Patent specification 
No.:EP1563308
Date:19.10.2011
Language:EN
[2011/42]
Search report(s)International search report - published on:US19.05.2005
(Supplementary) European search report - dispatched on:EP30.10.2006
ClassificationIPC:G01N33/53, C07K16/28
[2006/48]
CPC:
C07K14/475 (EP,US); A61P35/00 (EP); C07K16/22 (EP,US);
C07K16/28 (EP,US); G01N33/57488 (EP,US); A61K2039/505 (EP,US);
A61K38/00 (EP,US); C12N2799/026 (EP,US); G01N2800/52 (EP,US) (-)
Former IPC [2005/33]G01N33/574, G01N33/53, G01N33/543, G01N33/563, A61K39/395, C07K16/00
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   RO,   SE,   SI,   SK,   TR [2005/33]
TitleGerman:VERFAHREN UND KITS ZUR TUMORIGENIZITÄTSDIAGNOSE[2005/33]
English:METHODS AND KITS FOR DIAGNOSING TUMORIGENICITY[2005/33]
French:PROCEDES ET TROUSSES POUR DIAGNOSTIQUER UNE CANCEROGENICITE[2005/33]
Biological materialThis application mentions deposited biological material, check the file for details
Entry into regional phase26.05.2005National basic fee paid 
26.05.2005Search fee paid 
26.05.2005Designation fee(s) paid 
26.05.2005Examination fee paid 
Examination procedure27.05.2004Request for preliminary examination filed
International Preliminary Examining Authority: US
26.05.2005Examination requested  [2005/33]
12.06.2007Despatch of a communication from the examining division (Time limit: M06)
26.10.2007Reply to a communication from the examining division
08.02.2008Despatch of a communication from the examining division (Time limit: M04)
09.06.2008Reply to a communication from the examining division
25.11.2008Despatch of a communication from the examining division (Time limit: M06)
20.05.2009Reply to a communication from the examining division
18.11.2009Despatch of a communication from the examining division (Time limit: M06)
06.07.2010Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time
14.09.2010Reply to a communication from the examining division
18.11.2010Despatch of a communication from the examining division (Time limit: M02)
14.01.2011Reply to a communication from the examining division
18.04.2011Communication of intention to grant the patent
25.08.2011Fee for grant paid
25.08.2011Fee for publishing/printing paid
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  12.06.2007
Opposition(s)20.07.2012No opposition filed within time limit [2012/39]
Request for further processing for:The application is deemed to be withdrawn due to failure to reply to the examination report
14.09.2010Request for further processing filed
14.09.2010Full payment received (date of receipt of payment)
Request granted
28.09.2010Decision despatched
Fees paidRenewal fee
26.10.2005Renewal fee patent year 03
26.10.2006Renewal fee patent year 04
12.10.2007Renewal fee patent year 05
14.10.2008Renewal fee patent year 06
13.10.2009Renewal fee patent year 07
25.10.2010Renewal fee patent year 08
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipAT19.10.2011
CY19.10.2011
CZ19.10.2011
DK19.10.2011
EE19.10.2011
FI19.10.2011
HU19.10.2011
NL19.10.2011
RO19.10.2011
SE19.10.2011
SI19.10.2011
SK19.10.2011
TR19.10.2011
IE27.10.2011
IT27.10.2011
LU27.10.2011
CH31.10.2011
LI31.10.2011
MC31.10.2011
BG19.01.2012
GR20.01.2012
PT20.02.2012
[2013/45]
Former [2013/44]AT19.10.2011
CY19.10.2011
CZ19.10.2011
DK19.10.2011
EE19.10.2011
FI19.10.2011
NL19.10.2011
RO19.10.2011
SE19.10.2011
SI19.10.2011
SK19.10.2011
TR19.10.2011
IE27.10.2011
IT27.10.2011
LU27.10.2011
CH31.10.2011
LI31.10.2011
MC31.10.2011
BG19.01.2012
GR20.01.2012
PT20.02.2012
Former [2013/29]AT19.10.2011
CY19.10.2011
CZ19.10.2011
DK19.10.2011
EE19.10.2011
FI19.10.2011
NL19.10.2011
RO19.10.2011
SE19.10.2011
SI19.10.2011
SK19.10.2011
IE27.10.2011
IT27.10.2011
LU27.10.2011
CH31.10.2011
LI31.10.2011
MC31.10.2011
BG19.01.2012
GR20.01.2012
PT20.02.2012
Former [2013/25]AT19.10.2011
CY19.10.2011
CZ19.10.2011
DK19.10.2011
EE19.10.2011
NL19.10.2011
RO19.10.2011
SE19.10.2011
SI19.10.2011
SK19.10.2011
IE27.10.2011
IT27.10.2011
LU27.10.2011
CH31.10.2011
LI31.10.2011
MC31.10.2011
BG19.01.2012
GR20.01.2012
PT20.02.2012
Former [2013/07]AT19.10.2011
CY19.10.2011
CZ19.10.2011
DK19.10.2011
EE19.10.2011
NL19.10.2011
RO19.10.2011
SE19.10.2011
SI19.10.2011
SK19.10.2011
IE27.10.2011
IT27.10.2011
CH31.10.2011
LI31.10.2011
MC31.10.2011
BG19.01.2012
GR20.01.2012
PT20.02.2012
Former [2012/47]CY19.10.2011
CZ19.10.2011
DK19.10.2011
EE19.10.2011
NL19.10.2011
RO19.10.2011
SE19.10.2011
SI19.10.2011
SK19.10.2011
IE27.10.2011
IT27.10.2011
CH31.10.2011
LI31.10.2011
MC31.10.2011
BG19.01.2012
GR20.01.2012
PT20.02.2012
Former [2012/37]CY19.10.2011
CZ19.10.2011
DK19.10.2011
EE19.10.2011
NL19.10.2011
RO19.10.2011
SE19.10.2011
SI19.10.2011
SK19.10.2011
IT27.10.2011
CH31.10.2011
LI31.10.2011
MC31.10.2011
BG19.01.2012
GR20.01.2012
PT20.02.2012
Former [2012/36]CY19.10.2011
CZ19.10.2011
DK19.10.2011
EE19.10.2011
NL19.10.2011
RO19.10.2011
SE19.10.2011
SI19.10.2011
SK19.10.2011
CH31.10.2011
LI31.10.2011
MC31.10.2011
BG19.01.2012
GR20.01.2012
PT20.02.2012
Former [2012/35]CY19.10.2011
CZ19.10.2011
DK19.10.2011
EE19.10.2011
NL19.10.2011
SE19.10.2011
SI19.10.2011
CH31.10.2011
LI31.10.2011
MC31.10.2011
BG19.01.2012
GR20.01.2012
PT20.02.2012
Former [2012/34]CY19.10.2011
CZ19.10.2011
NL19.10.2011
SE19.10.2011
SI19.10.2011
CH31.10.2011
LI31.10.2011
MC31.10.2011
GR20.01.2012
PT20.02.2012
Former [2012/33]CY19.10.2011
NL19.10.2011
SE19.10.2011
SI19.10.2011
CH31.10.2011
LI31.10.2011
MC31.10.2011
GR20.01.2012
PT20.02.2012
Former [2012/28]CY19.10.2011
NL19.10.2011
SE19.10.2011
SI19.10.2011
MC31.10.2011
GR20.01.2012
PT20.02.2012
Former [2012/24]NL19.10.2011
SE19.10.2011
SI19.10.2011
MC31.10.2011
GR20.01.2012
PT20.02.2012
Former [2012/23]NL19.10.2011
GR20.01.2012
PT20.02.2012
Documents cited:Search[X]US2002025543  (SERRERO GINETTE [US]) [X] 1-10 * the whole document *;
 [A]US2002061859  (SERRERO GINETTE [US]) [A] 1-10 * the whole document *;
 [A]  - LU R ET AL, "Mediation of estrogen mitogenic effect in human breast cancer MCF-7 cells by PC-cell-derived growth factor (PCDGF/granulin precursor).", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. 2 JAN 2001, (20010102), vol. 98, no. 1, ISSN 0027-8424, pages 142 - 147, XP002337169 [A] 1-10 * the whole document *

DOI:   http://dx.doi.org/10.1073/pnas.011525198
International search[X]US6309826  (SERRERO GINETTE [US])
by applicantUS5416192
    - SWERDLOW ET AL., BMJ, (1997), vol. 314, page 1507
    - KRONZ ET AL., CANCER, (19991201), vol. 86, no. 11, pages 2426 - 2435
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.